FGFR3 , TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study-Reference-Cited by-同舟云学术

FGFR3 , TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study

Published:2017-06 Issue:6 Volume:197 Page:1410-1418
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Beukers Willemien¹,van der Keur Kirstin A.¹,Kandimalla Raju¹,Vergouwe Yvonne²,Steyerberg Ewout W.²,Boormans Joost L.³,Jensen Jorgen B.⁴,Lorente José A.⁵,Real Francisco X.⁶⁷,Segersten Ulrike⁸,Orntoft Torben F.⁹,Malats Nuria⁷,Malmström Per-Uno⁸,Dyrskjot Lars⁹,Zwarthoff Ellen C.¹

Affiliation:

1. Department of Pathology, Erasmus Medical Centre, Rotterdam, the Netherlands

2. Department of Public Health, Erasmus Medical Centre, Rotterdam, the Netherlands

3. Department of Urology, Erasmus Medical Centre, Rotterdam, the Netherlands

4. Department of Urology, Aarhus University Hospital, Aarhus, Denmark

5. Servei d’Urologia, Hospital del Mar, Barcelona, Spain

6. Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain

7. Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, Spanish National Cancer Research Centre-CNIO, Madrid, Spain

8. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

9. Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Bladder cancer detection in patients with gross haematuria: computed tomography urography with enhancement-triggered scan versus flexible cystoscopy;Helenius;Scand J Urol,2015

2. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer;Witjes;Nat Clin Pract Urol,2007

3. Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison;van der Aa;BJU Int,2008

4. Detection of recurrent bladder cancer: NMP22 test or urine cytology?;Hosseini;Urol J,2012

5. Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer;Schmitz-Drager;Urol Oncol,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Biosensors in Bladder Cancer;Critical Reviews in Analytical Chemistry;2024-07-08

2. Advances in Liquid Biopsy for Diagnosis of Bladder Cancer;International Neurourology Journal;2024-06-30

3. A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy;European Urology Open Science;2024-04

4. New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine;Cancers;2024-02-16

5. OTX Genes in Adult Tissues;International Journal of Molecular Sciences;2023-11-30